Open access
Open access
Powered by Google Translator Translator

Neurology

Systematic review: Autoimmune encephalitis related to cancer treatment with immune checkpoint inhibitors – nivolumab was responsible for 61% of cases; onset occurred after a median of 3.5 treatment cycles, but very early and late presentations were common

20 May, 2021 | 08:13h | UTC

Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review – Neurology (link to abstract – $ for full-text)

 


NICE Guideline Update | Headaches in over 12s: diagnosis and management.

18 May, 2021 | 07:14h | UTC

Headaches in over 12s: diagnosis and management – National Institute for Health and Care Excellence

 


2 recent meta-analysis highlight the benefits of short term (30 days) dual antiplatelet therapy with aspirin + clopidogrel in patients within 24 hours of high-risk transient ischemic attack or mild-moderate ischemic stroke.

17 May, 2021 | 08:16h | UTC

Meta-analysis 1: Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials – Stroke

Meta-analysis 2: Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials – Circulation (link to abstract – $ for full-text)

Commentary: Dual vs. Monotherapy Antiplatelet Agents in Secondary Stroke Prevention – American College of Cardiology

Related Guideline: Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke – The BMJ

 


Unnecessary care? 1 in 3 patients with advanced dementia and atrial fibrillation still given anticoagulants.

17 May, 2021 | 08:13h | UTC

Unnecessary care? 1 in 3 patients with advanced dementia and AFib still given anticoagulants – Cardiovascular Business

Original study: Anticoagulant Use for Atrial Fibrillation Among Persons With Advanced Dementia at the End of Life – JAMA Internal Medicine (free for a limited period)

Editorial: Anticoagulation at the End of Life: Time for a Rational Framework (free for a limited period)

 


Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.

14 May, 2021 | 08:30h | UTC

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Podcast with the author: Dr Paula Rochon talks with The Lancet Healthy Longevity about polypharmacy in older people through a sex and gender lens

Related: Reducing Inappropriate Medication Use & Polypharmacy (several articles and commentaries on the subject) AND Polypharmacy Management in Older Patients – Mayo Clinic Proceedings AND Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt internationa AND Eliminating Medication Overload: A National Action Plan AND Deprescribing in Older Adults With Cardiovascular Disease – Journal of the American College of Cardiology

 

Commentary on Twitter

 


Simplified decision aid: neuropathic pain treatment options in primary care.

14 May, 2021 | 08:17h | UTC

PEER simplified decision aid: neuropathic pain treatment options in primary care – Canadian Family Physician

 


Systematic review: Treatments for unruptured intracranial aneurysms – There is currently insufficient good-quality evidence to support either conservative treatment or interventional treatments (microsurgical clipping or endovascular coiling)

13 May, 2021 | 05:51h | UTC

Treatments for unruptured intracranial aneurysms – Cochrane Library

Summary: Treatments for unruptured intracranial aneurysms – Cochrane Library

 


Review: Diagnosis and treatment of unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage

13 May, 2021 | 05:53h | UTC

Diagnosis and Treatment of Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage – Mayo Clinic Proceedings

 


Eight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

12 May, 2021 | 08:55h | UTC

Eight out of ten people hospitalized with COVID-19 develop neurological problems – University of Pittsburgh

Original study: Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium – JAMA Network Open

Related: [Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

 


Review: Diagnosis and management of headache.

12 May, 2021 | 08:36h | UTC

Diagnosis and Management of Headache: A Review – JAMA (free for a limited period)

Audio clinical review: Diagnosis and Management of Headache, Part 1 – JAMA

 


Review: Neurologic assessment of the neurocritical care patient.

12 May, 2021 | 08:24h | UTC

Neurologic Assessment of the Neurocritical Care Patient – Frontiers in Neurology

 


Population-based cohort study: Youngest children in class are more likely to be diagnosed with a learning disability

11 May, 2021 | 09:08h | UTC

Relative age and specific learning disorder diagnoses: A Finnish population‐based cohort study – JCCP Advances

Commentary: Youngest children in class are more likely to be diagnosed with a learning disability – University of Turku

 


Guideline: Diagnosis and treatment of neurogenic dysphagia.

6 May, 2021 | 08:51h | UTC

Diagnosis and treatment of neurogenic dysphagia – S1 guideline of the German Society of Neurology – Neurological Research and Practice

 


Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases

5 May, 2021 | 08:15h | UTC

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases – Mayo Clinic Proceedings

 


[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

4 May, 2021 | 08:44h | UTC

Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – medRxiv

Commentary: Study finds one-third of COVID-19 patients experience neurological symptoms – News Medical

 


M-A: A third of kids develop a mental health problem after concussion

4 May, 2021 | 08:35h | UTC

News Release: A third of kids develop a mental health problem after concussion – Murdoch Childrens Research Institute

Original Study: Mental health after paediatric concussion: a systematic review and meta-analysis – British Journal of Sports Medicine

 


Review: Parkinson’s disease

4 May, 2021 | 08:28h | UTC

Parkinson’s disease – The Lancet

 


Cohort Study: The risk of overdose with concomitant use of Z-Drugs (zolpidem, zopiclone, zaleplon) and prescription opioids is significantly increased

30 Apr, 2021 | 08:32h | UTC

The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study – American Journal of Psychiatry (link to abstract – $ for full-text)

Commentary: Co-prescribing Opioids, Z-Drugs May Increase Risk of Overdose – Psychiatric News Alert

 


AHA/ASA Guidance: Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – “No heparin products in any dose should be given.”

30 Apr, 2021 | 08:25h | UTC

Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – Stroke

News release: Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine – American Heart Association

Related: ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia

 


COVID-19 ‘brain fog’ inspires search for causes and treatments

30 Apr, 2021 | 08:13h | UTC

COVID-19 ‘brain fog’ inspires search for causes and treatments – Science (a few articles per month are free)

 


Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19

27 Apr, 2021 | 08:29h | UTC

Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19 – American Journal of Physical Medicine & Rehabilitation

 


Clinical review of 43 patients with COVID-19-associated Acute Transverse Myelitis and 3 patients with Acute Transverse Myelitis reported post-vaccination

27 Apr, 2021 | 08:32h | UTC

Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) – Frontiers in Immunology

Commentary: Rare neurological condition linked to COVID-19 cases in 21 countries – Houston Methodist

 


SARS-CoV-2 and Stroke Characteristics – higher rate of large vessel occlusions and stroke in young patients

25 Apr, 2021 | 22:01h | UTC

SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group – Stroke

 

Commentary on Twitter

 


RCT: Promising results with vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischemic stroke

25 Apr, 2021 | 21:10h | UTC

Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial – The Lancet

Commentary: Vagus nerve stimulation: a potential new treatment for ischaemic stroke – The Lancet

 

Commentary on Twitter

 


Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19

23 Apr, 2021 | 08:39h | UTC

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men – JAMA Network Open

Commentary: ‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk – Cardiovascular Business

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.